嘉裏物流(00636.HK)夥順豐推藥物配送服務
嘉裏物流(00636.HK)公佈,旗下嘉裏醫藥和順豐香港合作,推「家﹒藥配送」服務,爲因疫情而未能離家求醫或配藥的弱勢社羣病人提供相關服務。
「家﹒藥配送」服務由3月11日開始,爲本地非牟利組織旗下社區藥房配送藥物,整個配送過程可透過數碼追蹤系統緊密監控,病人亦可從順豐香港官網及手機應用程式中查閱最新派送狀況及派遞人員的資料。
嘉裏物流表示,「家﹒藥配送」的派遞人員均在派送前接受病毒快速檢測,亦會定時爲相關用具進行消毒,確保安全衛生。該服務以量身訂製的機制,取得病人同意、安全的藥物包裝和標籤、獨立物流箱、個別派遞員姓名和聯絡電話號碼的通知,並由密碼保護的交收過程。(ca/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.